Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Burcon NutraScience Corporation    BU   CA1208311029

BURCON NUTRASCIENCE CORPORATION

(BU)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Burcon NutraScience : Announces Closing of C$11.5 Million Bought Deal

share with twitter share with LinkedIn share with facebook
share via e-mail
02/19/2020 | 12:25pm EDT

DGAP-News: Burcon NutraScience Corp. / Key word(s): Miscellaneous
Burcon NutraScience Corporation Announces Closing of C$11.5 Million Bought Deal

19.02.2020 / 17:20
The issuer is solely responsible for the content of this announcement.


Burcon NutraScience Corporation Announces Closing of C$11.5 Million Bought Deal

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

Vancouver, February 19, 2020 / - Burcon NutraScience Corporation (the "Company" or "Burcon") (TSX:BU) is pleased to confirm the closing of its previously announced bought deal offering for gross proceeds of C$11,500,690 (the "Offering").

Co-lead underwriters Canaccord Genuity Corp. and Beacon Securities Limited, together with Eight Capital and Paradigm Capital Inc. (collectively, the "Underwriters") purchased from Burcon, on a bought deal basis, 6,452,000 units of the Company ("Units") at a price of C$1.55 per Unit for gross proceeds of C$10,000,600. The Underwriters also exercised the over-allotment option in full and purchased an additional 967,800 Units at a price of C$1.55 for additional gross proceeds to the Company of C$1,500,090.

Each Unit is comprised of one common share of the Company (a "Common Share") and one-half of one Common Share purchase warrant (each whole Common Share purchase warrant, a "Warrant"). Each Warrant will be exercisable to acquire one Common Share at an exercise price of $2.00 for a period of 24 months from the closing of the Offering.

The net proceeds of the Offering will be used by the Company for research and development activities, the maintenance, strengthening and expansion of its patent portfolio and general corporate purposes.

"We are pleased to have completed this bought deal financing," said Johann F. Tergesen, Burcon's president and chief executive officer, adding, "The funds will enable Burcon to further accelerate our key opportunities and the development of our nutritious and great-tasting plant-based proteins."

The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. This news release will not constitute an offer to sell or the solicitation of an offer to buy nor will there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful.


About Burcon NutraScience Corporation

Burcon is a global technology leader in the development of plant-based proteins. With over 270 issued patents and more than 260 additional patent applications, developed over a span of more than twenty years, Burcon has grown an extensive portfolio of composition, application, and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed and more. In 2019, Merit Functional Foods Corporation was established in a joint venture by Burcon and three veteran food industry executives. Merit Foods is building a state-of-the-art protein production facility in Manitoba, Canada, where it will produce, under license, Burcon's novel pea and canola protein ingredients. For more information visit www.burcon.ca


Forward-Looking Information Cautionary Statement

The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward looking statements or forward-looking information can be identified by words such as "anticipate," "intend," "plan," "goal," "project," "estimate," "expect," "believe", "future," "likely," "may," "should," "could", "will" and similar references to future periods. All statements other than statements of historical fact included in this release are forward-looking statements, including, without limitation, statements regarding the expected use of proceeds contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the actual results of business negotiations, marketing activities, adverse general economic, market or business conditions, regulatory changes and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form dated June 28, 2019 filed with the Canadian securities administrators on www.sedar.com. Any forward-looking statement or information only speaks as of the date on which it was made and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and accordingly, investors should not rely on such statements. CLARISOY is a trademark of Archer Daniels Midland Company.

Investor Contact
Paul Lam
Manager, Business Development
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca
www.burcon.ca

Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM



19.02.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


979377  19.02.2020 

fncls.ssp?fn=show_t_gif&application_id=979377&application_name=news&site_id=zonebourse

© EQS 2020
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on BURCON NUTRASCIENCE CORPOR
03/11BURCON NUTRASCIENCE CORP. : Burcon to Participate at the 32nd Annual ROTH Confer..
EQ
03/10Burcon to Participate at the 32nd Annual ROTH Conference on March 15-17, 2020
NE
02/19BURCON NUTRASCIENCE : Announces Closing of C$11.5 Million Bought Deal
EQ
02/19Burcon NutraScience Corporation Announces Closing of C$11.5 Million Bought De..
NE
02/13BURCON NUTRASCIENCE CORP. : Burcon Commences Trading on the OTCQB(R) Venture Mar..
EQ
02/12BURCON NUTRASCIENCE : Commences Trading on the OTCQB® Venture Market in the U.S.
PU
02/12Burcon Commences Trading on the OTCQB(R) Venture Market in the U.S.
NE
01/29BURCON NUTRASCIENCE CORP. : Burcon NutraScience Corporation Announces C$10 Milli..
EQ
01/28Burcon NutraScience to raise C$10 million via bought deal
RE
01/28BURCON NUTRASCIENCE CORPORATION : Announces C$10 Million Bought Deal
AQ
More news
Financials (CAD)
Sales 2020 0,03 M
EBIT 2020 -
Net income 2020 -
Debt 2020 -
Yield 2020 -
P/E ratio 2020 -15,1x
P/E ratio 2021 -27,7x
Capi. / Sales2020 2 995x
Capi. / Sales2021 19,5x
Capitalization 79,4 M
Chart BURCON NUTRASCIENCE CORPORATION
Duration : Period :
Burcon NutraScience Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BURCON NUTRASCIENCE CORPOR
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 2,88  CAD
Last Close Price 0,83  CAD
Spread / Highest target 292%
Spread / Average Target 246%
Spread / Lowest Target 201%
EPS Revisions
Managers
NameTitle
Johann Franz Tergesen President & Chief Executive Officer
David Lorne John Tyrrell Chairman
Jade Cheng Chief Financial Officer & Treasurer
Martin Hans Schweizer Vice President-Technical Development
Mei Wah Chau Director
Sector and Competitors
1st jan.Capitalization (M$)
BURCON NUTRASCIENCE CORPORATION-14.43%56
BY-HEALTH CO., LTD.3.59%3 877
BALCHEM CORPORATION-6.25%3 177
THE SIMPLY GOOD FOODS COMPANY-42.89%1 607
GRAPE KING BIO LTD2.46%864
MEDIFAST, INC.-36.51%819